These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology. J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144 [TBL] [Abstract][Full Text] [Related]
5. [Chinese expert consensus on the multidisciplinary clinical diagnosis and treatment of stage Ⅲ non-small cell lung cancer (2019)]. ; Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):881-890. PubMed ID: 31874543 [TBL] [Abstract][Full Text] [Related]
6. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee. Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176 [TBL] [Abstract][Full Text] [Related]
7. Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology. Gridelli C; Ardizzoni A; Douillard JY; Hanna N; Manegold C; Perrone F; Pirker R; Rosell R; Shepherd FA; De Petris L; Di Maio M; de Marinis F Lung Cancer; 2010 Jun; 68(3):319-31. PubMed ID: 20036027 [TBL] [Abstract][Full Text] [Related]
8. European Society of Medical Oncology (ESMO) guidelines for oncogene-addicted metastatic non-small cell lung cancer (NSCLC): a personalized treatment for each patient. Suay G; Aparisi F; Juan-Vidal O Chin Clin Oncol; 2024 Jun; 13(3):46. PubMed ID: 38378474 [No Abstract] [Full Text] [Related]
9. Incorporation of crizotinib into the NCCN guidelines. Riely GJ; Chaft JE; Ladanyi M; Kris MG J Natl Compr Canc Netw; 2011 Dec; 9(12):1328-30. PubMed ID: 22157552 [No Abstract] [Full Text] [Related]
10. Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP). Garrido P; de Castro J; Concha Á; Felip E; Isla D; López-Ríos F; Paz-Ares L; Ramírez J; Sanz J; Gómez JJ Clin Transl Oncol; 2012 May; 14(5):338-49. PubMed ID: 22551539 [TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. Videtic GMM; Donington J; Giuliani M; Heinzerling J; Karas TZ; Kelsey CR; Lally BE; Latzka K; Lo SS; Moghanaki D; Movsas B; Rimner A; Roach M; Rodrigues G; Shirvani SM; Simone CB; Timmerman R; Daly ME Pract Radiat Oncol; 2017; 7(5):295-301. PubMed ID: 28596092 [TBL] [Abstract][Full Text] [Related]
12. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Hanna N; Johnson D; Temin S; Baker S; Brahmer J; Ellis PM; Giaccone G; Hesketh PJ; Jaiyesimi I; Leighl NB; Riely GJ; Schiller JH; Schneider BJ; Smith TJ; Tashbar J; Biermann WA; Masters G J Clin Oncol; 2017 Oct; 35(30):3484-3515. PubMed ID: 28806116 [TBL] [Abstract][Full Text] [Related]
13. A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer. Ellis PM; Blais N; Soulieres D; Ionescu DN; Kashyap M; Liu G; Melosky B; Reiman T; Romeo P; Shepherd FA; Tsao MS; Leighl NB J Thorac Oncol; 2011 Aug; 6(8):1379-91. PubMed ID: 21709590 [TBL] [Abstract][Full Text] [Related]
14. Recommendations for the analysis of ALK gene rearrangements in non-small-cell lung cancer: a consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and Cytopathology. Marchetti A; Ardizzoni A; Papotti M; Crinò L; Rossi G; Gridelli C; Barberis M; Maiorano E; Normanno N; Taddei GL; Scagliotti G; Clemente C; Pinto C J Thorac Oncol; 2013 Mar; 8(3):352-8. PubMed ID: 23407559 [TBL] [Abstract][Full Text] [Related]
15. Clinical management of stage III non-small cell lung cancer in India: An expert consensus statement. Batra U; Prabhash K; Agarwal JP; Darlong L; Munshi A; Penumadu P; Thangakunam B; Bansal A Asia Pac J Clin Oncol; 2023 Dec; 19(6):606-617. PubMed ID: 36815621 [TBL] [Abstract][Full Text] [Related]
16. [Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition)]. ; Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):539-574. PubMed ID: 37460438 [TBL] [Abstract][Full Text] [Related]
17. Management of Early-Stage Resected Non-Small Cell Lung Cancer: Consensus Statement of the Lung cancer Consortium. Allehebi A; Kattan KA; Rujaib MA; Dayel FA; Black E; Mahrous M; AlNassar M; Hussaini HA; Twairgi AA; Abdelhafeiz N; Omair AA; Shehri SA; Al-Shamsi HO; Jazieh AR Cancer Treat Res Commun; 2022; 31():100538. PubMed ID: 35220069 [TBL] [Abstract][Full Text] [Related]
18. Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS. Wu YL; Planchard D; Lu S; Sun H; Yamamoto N; Kim DW; Tan DSW; Yang JC; Azrif M; Mitsudomi T; Park K; Soo RA; Chang JWC; Alip A; Peters S; Douillard JY Ann Oncol; 2019 Feb; 30(2):171-210. PubMed ID: 30596843 [TBL] [Abstract][Full Text] [Related]
19. Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman J; Chirieac LR; D'Amico TA; DeCamp MM; Dilling TJ; Dobelbower M; Doebele RC; Govindan R; Gubens MA; Hennon M; Horn L; Komaki R; Lackner RP; Lanuti M; Leal TA; Leisch LJ; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Reckamp K; Riely GJ; Schild SE; Shapiro TA; Stevenson J; Swanson SJ; Tauer K; Yang SC; Gregory K; Hughes M J Natl Compr Canc Netw; 2017 Apr; 15(4):504-535. PubMed ID: 28404761 [TBL] [Abstract][Full Text] [Related]
20. Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010. Felip E; Gridelli C; Baas P; Rosell R; Stahel R; Ann Oncol; 2011 Jul; 22(7):1507-1519. PubMed ID: 21536661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]